Loading...

DCAL Dishman Carbogen Amcis Ltd Other Situations Announcement

Dshm

DCL

Dishman Carbogen Amcis Ltd

(DCAL)

2025 Announcement

Show Summary

Show Summary

US FDA Inspection

Investor Meeting

Major Expansion Announcement

Annual Compliance Report

Earnings Call Transcript

Chairman Demise

Investor Call Update

Investor Presentation

Secretarial Auditor Appointed

Investor Conference Call

NCDs Covenant Amendment

Manufacturing License Granted

Credit Rating Update

Manufacturing License Granted

Compliance Certificate

Director Changes

GMP Compliance Achieved

GMP Compliance Achieved

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Investor Conference Call

New CEO Appointment

Management Change

Swissmedic Approval

Compliance Certificate

Director Cessation

Earnings Call Transcript

Management Change

Earnings Conference Call

Investor Presentation

Director Appointment

Investor Conference Call

Management Change

Quarterly Compliance

Earnings Call Transcript

Earnings Call Recording

Investor Presentation

Conference Call

Volume Movement Clarification

Allotment Approval

Compliance Certificate Subm...

FDA Inspection Completion

Change in Senior Management...

Investor Presentation

Compliance Report Submission

Conference Call

Financial Covenant Amendment

Financial Amendment

Submission of Compliance Ce...

Compliance Confirmation

Cessation of Directors

ANVISA Audit Completion

US FDA Inspection

Conference Call Recording

Investor Presentation

Management Change

Conference Call Intimation

GMP Compliance Certificate ...

GMP Compliance Inspection R...

Credit Rating Disclosure

Certificate under Reg. 74 (...

Earnings Call Recording

Investor Presentation

Transfer of Equity Shares t...

Conference Call

Certificate Submission

Inspection Completion

Financial Statements

Management Changes

Conference Call

Management Changes

Management Changes

Financial Results Transcript

Financial Results

Conference Call

External Links:

Data:

Dishman Carbogen Amcis Ltd's subsidiary CARBOGEN AMCIS (Shanghai) Co. Ltd. received a Drug Manufacturing License from China's National Medical Product Administration on April 8, 2025.

AI Assistant

Dishman Carbogen Amcis Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.